Target intelligence / Profile preview

Atlastin GTPase 2 (ATL2)

Target
ATL2
Molecular classification
Enzyme (GTPase), Membrane-anchored GTPase, Dynamin-like GTPase, Other (Endoplasmic reticulum membrane fusion factor)
01

Overview

Atlastin GTPase 2 (ATL2) is a membrane-anchored, dynamin-like GTPase that mediates the GTP-dependent homotypic fusion of endoplasmic reticulum (ER) membranes, maintaining the continuous and dynamic tubular network of the ER[1][3][4]. ATL2 activity is essential for ER network integrity, Golgi organization, and proper organelle and lipid droplet distribution[1][2][4]. ATL2 also helps recruit autophagy machinery to ER-associated sites and supports the formation of replication organelles in certain viral infections[2]. Although mutations in its paralog ATL1 are more strongly linked to hereditary spastic paraplegia, ATL2 is ubiquitously expressed in peripheral tissues and any defect can disturb ER morphology with important cellular consequences[1][4]. ATL2 functions by forming loose homodimers in a GTP-dependent manner; subsequent GTP hydrolysis tightens the dimer to drive membrane fusion, after which the dimer disassembles and ATL2 resets for further cycles[1][4]. No known drugs targeting ATL2 are clinically validated as of the current knowledge base.

Other names
Atlastin-2ARL6IP2ATL-2atlastin2ADP-ribosylation factor-like protein 6-interacting protein 2ARL3IP2aip-2
02

Biological functions

Endoplasmic reticulum membrane fusionMaintenance of endoplasmic reticulum tubular network organizationGolgi organizationProtein homooligomerizationOrganelle distributionAutophagy initiation (supports autophagy machinery recruitment at ER)Membrane remodeling during virus replication
03

Disease associations

Neurodegenerative disease (implicated in hereditary spastic paraplegia, especially ATL1 paralog)Lipid metabolism disorders (impacts lipid droplet size and secretion)Other (altered ER morphology impacting cell homeostasis)
04

Safety considerations

Potential for disruption of ER network leading to cell dysfunctionImpaired ER fusion linked to hereditary spastic paraplegias (primarily with ATL1 paralog)

Beyond the preview

Go deeper on Atlastin GTPase 2 (ATL2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Atlastin GTPase 2 (ATL2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call